CervoMed (CRVO) FCF Payout Ratio (2017 - 2018)

CervoMed (CRVO) posted FCF Payout Ratio of 0.03 for Q1 2018, up 82.35% sequentially from 0.15 in Q4 2017, and down 52.04% YoY from 0.05 in Q1 2017.

CervoMed (CRVO) FCF Payout Ratio (2017 - 2018) Analysis & Trends

CervoMed has reported FCF Payout Ratio for 2 years, with the latest figure at 0.03 in Q1 2018.

Quarterly FCF Payout Ratio fell 52.04% year-over-year to 0.03 in Q1 2018, while the trailing twelve-month figure through Dec 2018 was 0.01 (up 92.14% YoY) and the FY2018 annual result came in at 0.01, up 91.85% from the prior year.
FCF Payout Ratio climbed to 0.03 in Q1 2018 per CRVO's latest filing, from 0.15 in the prior quarter.
Over five years, FCF Payout Ratio peaked at 0.02 in Q1 2017 and troughed at 0.18 in Q2 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Cover (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	0.17
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.07
10	CervoMed	26.64 Mn	26.64 Mn	-	-

Download Data